Intellectual Property, COVID-19 Vaccines and Equity: A Public Health and Human Rights Critique
The debates surrounding Intellectual Property (IP) have opened a front in the geopolitical struggle for COVID-19 vaccine access and distribution.Specific to vaccine manufacture, one Garden Ornamnent route by which local production can be encouraged in low- to middle-income countries would be to ease IP restrictions by such mechanisms as a temporary